| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |